Effect of Expansion Media on Functional Characteristics of Bone Marrow-Derived Mesenchymal Stromal Cells

被引:6
|
作者
Jakl, Viktoria [1 ]
Popp, Tanja [2 ]
Haupt, Julian [2 ,3 ]
Port, Matthias [2 ]
Roesler, Reinhild [4 ]
Wiese, Sebastian [4 ]
Friemert, Benedikt [3 ]
Rojewski, Markus T. [1 ,5 ,6 ]
Schrezenmeier, Hubert [1 ,5 ,6 ]
机构
[1] Univ Hosp Ulm, Inst Transfus Med, D-89081 Ulm, Germany
[2] Bundeswehr Inst Radiobiol, D-80937 Munich, Germany
[3] Army Hosp Ulm, Clin Trauma Surg & Orthoped, Ulm, Germany
[4] Ulm Univ, Med Ctr, Core Unit Mass Spectrometry & Prote, D-89081 Ulm, Germany
[5] German Red Cross Blood Donat Serv Baden Wurttember, Inst Clin Transfus Med & Immunogenet Ulm, D-89081 Ulm, Germany
[6] Univ Hosp Ulm, D-89081 Ulm, Germany
关键词
mesenchymal stromal cells; mesenchymal stem cells; media; serum-free; xenogeneic-free; platelet lysate; HEPATOCYTE GROWTH-FACTOR; VERSUS-HOST-DISEASE; FETAL BOVINE SERUM; MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-PRODUCING CELLS; HUMAN PLATELET LYSATE; STEM-CELLS; TGF-BETA; ENDOTHELIAL-CELLS; PROMOTES ANGIOGENESIS;
D O I
10.3390/cells12162105
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The therapeutic efficacy of mesenchymal stromal cells (MSCs) has been shown to rely on their immunomodulatory and regenerative properties. In order to obtain sufficient numbers of cells for clinical applications, MSCs have to be expanded ex vivo. Expansion media with xenogeneic-free (XF) growth-promoting supplements like human platelet lysate (PL) or serum- and xenogeneicfree (SF/XF) formulations have been established as safe and efficient, and both groups provide different beneficial qualities. In this study, MSCs were expanded in XF or SF/XF media as well as in mixtures thereof. MSCs cultured in these media were analyzed for phenotypic and functional properties. MSC expansion was optimal with SF/XF conditions when PL was present. Metabolic patterns, consumption of growth factors, and secretome of MSCs differed depending on the type and concentration of supplement. The lactate per glucose yield increased along with a higher proportion of PL. Many factors in the supernatant of cultured MSCs showed distinct patterns depending on the supplement (e.g., FGF-2, TGF beta, and insulin only in PL-expanded MSC, and leptin, sCD40L PDGF-AA only in SF/XF-expanded MSC). This also resulted in changes in cell characteristics like migratory potential. These findings support current approaches where growth media may be utilized for priming MSCs for specific therapeutic applications.
引用
收藏
页数:31
相关论文
共 50 条
  • [31] Choice of xenogenic-free expansion media significantly influences the myogenic differentiation potential of human bone marrow-derived mesenchymal stromal cells
    Brun, Juliane
    Abruzzese, Tanja
    Rolauffs, Bernd
    Aicher, Wilhelm K.
    Hart, Melanie L.
    CYTOTHERAPY, 2016, 18 (03) : 344 - 359
  • [32] Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells
    Seib, F. Philipp
    Franke, Martina
    Jing, Duohui
    Werner, Carsten
    Bornhaeuser, Martin
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2009, 88 (05) : 257 - 271
  • [33] Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency
    Starc, Nadia
    Ingo, Daniela
    Conforti, Antonella
    Rossella, Valeria
    Tomao, Luigi
    Pitisci, Angela
    De Mattia, Fabiola
    Brigida, Immacolata
    Algeri, Mattia
    Montanari, Mauro
    Palumbo, Giuseppe
    Merli, Pietro
    Rossi, Paolo
    Aiuti, Alessandro
    Locatelli, Franco
    Bernardo, Maria Ester
    SCIENTIFIC REPORTS, 2017, 7
  • [34] Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency
    Nadia Starc
    Daniela Ingo
    Antonella Conforti
    Valeria Rossella
    Luigi Tomao
    Angela Pitisci
    Fabiola De Mattia
    Immacolata Brigida
    Mattia Algeri
    Mauro Montanari
    Giuseppe Palumbo
    Pietro Merli
    Paolo Rossi
    Alessandro Aiuti
    Franco Locatelli
    Maria Ester Bernardo
    Scientific Reports, 7
  • [35] Bone Marrow-Derived Mesenchymal Stromal Cells Promote Survival and Drug Resistance in Tumor Cells
    Bergfeld, Scott A.
    Blavier, Laurence
    DeClerck, Yves A.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (04) : 962 - 975
  • [36] Bone marrow-derived multipotent mesenchymal stromal cells from horses after euthanasia
    Schroeck, Carmen
    Eydt, Carina
    Geburek, Florian
    Kaiser, Lena
    Paebst, Felicitas
    Burk, Janina
    Pfarrer, Christiane
    Staszyk, Carsten
    VETERINARY MEDICINE AND SCIENCE, 2017, 3 (04): : 239 - 251
  • [37] Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells
    Najar, Mehdi
    Fayyad-Kazan, Mohammad
    Fayyad-Kazan, Hussein
    Meuleman, Nathalie
    Bron, Dominique
    Lagneaux, Laurence
    DATA IN BRIEF, 2016, 8 : 1111 - 1114
  • [38] Modulation of lymphocyte trafficking by bone marrow-derived mesenchymal stromal cells in multiple sclerosis
    Hares, Kelly
    Minton, Thomas
    Redondo, Juliana
    Bailey, Steven
    Cleaver, Jonathan
    Kemp, Kevin
    McGettrick, Helen
    Scolding, Neil
    Rice, Claire
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 870 - 870
  • [39] Functional Regeneration of Laryngeal Muscle Using Bone Marrow-Derived Stromal Cells
    Kanemaru, Shin-ichi
    Kitani, Yoshiharu
    Ohno, Satoshi
    Shigemoto, Taeko
    Kojima, Tsuyoshi
    Ishikawa, Seiji
    Mizuta, Masanobu
    Hirano, Shigeru
    Nakamura, Tatsuo
    Dezawa, Mari
    LARYNGOSCOPE, 2013, 123 (11): : 2728 - 2734
  • [40] ENHANCED TRANSFECTION OF HUMAN BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS WITH MESSENGER RNA
    Pennati, A.
    Pagenkopf, A. C.
    Kopp, L.
    Galipeau, J.
    CYTOTHERAPY, 2024, 26 (06) : S57 - S58